En | De
Sie sind hier: Urologie-Nephrologie » Tumoren/BPH 14. August 2020
Erweiterte Suche
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 6836  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 136716  
Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patients.
Int J Urol
Tomita Y, Tatsugami K, Nakaigawa N, Osawa T, Oya M, Kanayama H, Nakayama Kondoh C, Sassa N, Nishimura K, Nozawa M, Masumori N, Miyoshi Y, Kuroda S, Tanaka S, Kimura A, Tamada S.
PMID: 32789967 [PubMed - as supplied by publisher]

Detection of metastases in newly diagnosed prostate cancer by using 68Ga-PSMA PET/CT and its relationship with modified D'Amico risk classification.
Eur J Nucl Med Mol Imaging
Simsek DH, Sanli Y, Engin MN, Erdem S, Sanli O.
PMID: 32789600 [PubMed - as supplied by publisher]

Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial.
Eur J Nucl Med Mol Imaging
Jansen BHE, Bodar YJL, Zwezerijnen GJC, Meijer D, van der Voorn JP, Nieuwenhuijzen JA, Wondergem M, Roeleveld TA, Boellaard R, Hoekstra OS, van Moorselaar RJA, Oprea-Lager DE, Vis AN.
PMID: 32789599 [PubMed - as supplied by publisher]

Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge.
Eur J Case Rep Intern Med
Braddy A, Mogal RJ, Maddox AJ, Barlow ABT.
PMID: 32789141 [PubMed - as supplied by publisher]

Correction: gr/gr deletion predisposes to testicular germ cell tumour independently from altered spermatogenesis: results from the largest European study.
Eur J Hum Genet
Moreno-Mendoza D, Casamonti E, Paoli D, Chianese C, Riera-Escamilla A, Giachini C, Fino MG, Cioppi F, Lotti F, Vinci S, Magini A, Ars E, Sanchez-Curbelo J, Ruiz-Castane E, Lenzi A, Lombardo F, Krausz C.
PMID: 32788662 [PubMed - as supplied by publisher]

Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?
Cancer Imaging
de Leiris N, Leenhardt J, Boussat B, Montemagno C, Seiller A, Phan Sy O, Roux J, Laramas M, Verry C, Iriart C, Fiard G, Long JA, Descotes JL, Vuillez JP, Riou L, Djaileb L.
PMID: 32787923 [PubMed - as supplied by publisher]

Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study.
BMC Cancer
Houédé N, Rébillard X, Bouvet S, Kabani S, Fabbro-Peray P, Trétarre B, Ménégaux F.
PMID: 32787797 [PubMed - as supplied by publisher]

Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer.
J Med Chem
Noor A, Van Zuylekom JK, Rudd SE, Waldeck K, Roselt PD, Haskali MB, Wheatcroft MP, Yan E, Hicks RJ, Cullinane C, Donnelly PS.
PMID: 32786229 [PubMed - as supplied by publisher]

A systematic review of irreversible electroporation in localised prostate cancer treatment.
Morozov A, Taratkin M, Barret E, Singla N, Bezrukov E, Chinenov D, Enikeev M, Gomez Rivas J, Shpikina A, Enikeev D.
PMID: 32786087 [PubMed - as supplied by publisher]

Experts Develop New Guideline for Advanced Prostate Cancer.
Oncology (Williston Park)
Broderick JM.
PMID: 32785924 [PubMed - in process]

[Olaparib for metastatic prostate cancer-the PROfound trial].
Urologe A
Merseburger AS.
PMID: 32785732 [PubMed - as supplied by publisher]

Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer.
Bioengineering (Basel)
Ashrafizadeh M, Hushmandi K, Rahmani Moghadam E, Zarrin V, Hosseinzadeh Kashani S, Bokaie S, Najafi M, Tavakol S, Mohammadinejad R, Nabavi N, Hsieh CL, Zarepour A, Zare EN, Zarrabi A, Makvandi P.
PMID: 32784981 [PubMed]

Evaluation of MicroRNAs as Non-Invasive Diagnostic Markers in Urinary Cells from Patients with Suspected Prostate Cancer.
Diagnostics (Basel)
Borkowetz A, Lohse-Fischer A, Scholze J, Lotzkat U, Thomas C, Wirth MP, Fuessel S, Erdmann K.
PMID: 32784833 [PubMed]

Renal Cell Tumors: Uncovering the Biomarker Potential of ncRNAs.
Cancers (Basel)
Outeiro-Pinho G, Barros-Silva D, Correia MP, Henrique R, Jerónimo C.
PMID: 32784737 [PubMed]

Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications.
Int J Mol Sci
Minoli M, Kiener M, Thalmann GN, Kruithof-de Julio M, Seiler R.
PMID: 32784716 [PubMed - in process]

Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer.
Ashrafizadeh M, Hushmandi K, Hashemi M, Akbari ME, Kubatka P, Raei M, Koklesova L, Shahinozzaman M, Mohammadinejad R, Najafi M, Sethi G, Kumar AP, Zarrabi A.
PMID: 32784711 [PubMed - in process]

MiR-93/miR-375: Diagnostic Potential, Aggressiveness Correlation and Common Target Genes in Prostate Cancer.
Int J Mol Sci
Ciszkowicz E, Porzycki P, Semik M, Kaznowska E, Tyrka M.
PMID: 32784653 [PubMed - in process]

DNA Methylation as a Therapeutic Target for Bladder Cancer.
Nunes SP, Henrique R, Jerónimo C, Paramio JM.
PMID: 32784599 [PubMed - in process]

Preoperative detection of VI-RADS (Vesical Imaging-Reporting and Data System) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time-to-cystectomy: time to reconsider the need for primary deep trans-urethral resection of bladder tumor in case of locally advanced disease?
Del Giudice F, Leonardo C, Simone G, Pecoraro M, De Berardinis E, Cipollari S, Flammia S, Bicchetti M, Busetto GM, Chung BI, Gallucci M, Catalano C, Valeria P.
PMID: 32783347 [PubMed - as supplied by publisher]

The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy.
J Cell Physiol
Lai Y, Tang F, Huang Y, He C, Chen C, Zhao J, Wu W, He Z.
PMID: 32783202 [PubMed - as supplied by publisher]

   Artikel 1 - 20 / 136716    Seite 1 von 6836  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer





Haben Sie Ihr Passwort vergessen?


Neu bei My Medline?

Melden Sie sich bei My Medline an!


Mehr über My Medline erfahren

mehr >>


Sky right 1